Active, Not Recruiting
A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)
NCT06346067
- Conditions
- Advanced or Metastatic NRAS-mutant Melanoma, Melanoma, Neoplasms, +10 more
- Locations
-
- Mayo Clinic - Arizona Phoenix, Arizona, United States
- University of California, San Francisco San Francisco, California, United States
- The Melanoma and Skin Care Institute Englewood, Colorado, United States
- Mayo Clinic - Florida Jacksonville, Florida, United States